[1]
S. D. Juniar, M. Y. Alsagaff, B. S. Pikir, and P. Lestari, “Dapagliflozin Use in Heart Failure with Reduced Ejection Fraction Accompanied by Type 2 Diabetes Mellitus: A Systematic Review”, CCJ, vol. 3, no. 1, pp. 60–74, Mar. 2022.